Archives
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
S-Adenosylhomocysteine: Unraveling Its Central Role in Me...
2025-10-05
Explore how S-Adenosylhomocysteine, a vital methylation cycle regulator, influences metabolic signaling and epigenetic dynamics. This article offers a unique perspective by connecting SAH's biochemical actions to neural differentiation and disease models, backed by recent mechanistic research.
-
S-Adenosylhomocysteine: From Metabolic Intermediate to St...
2025-10-04
This article explores the transformative role of S-Adenosylhomocysteine (SAH) as more than a metabolic intermediate, elucidating its mechanistic impact on the methylation cycle, methyltransferase inhibition, and disease modeling. Integrating recent evidence—including neural differentiation findings under stress conditions—the discussion offers strategic guidance for translational researchers, highlights competitive and experimental landscapes, and positions SAH as an indispensable tool for high-impact discovery.
-
S-Adenosylhomocysteine: Optimizing Methylation Cycle Rese...
2025-10-03
Leverage S-Adenosylhomocysteine (SAH) as a precise methylation cycle regulator and metabolic intermediate for cutting-edge applications in enzyme inhibition and metabolic disease modeling. This guide unpacks experimental workflows, troubleshooting strategies, and advanced insights to empower reproducible, high-impact research across neurobiology, toxicology, and metabolic studies.
-
S-Adenosylhomocysteine: A Mechanistic Lever for Translati...
2025-10-02
Explore how S-Adenosylhomocysteine (SAH) is transforming translational research across metabolic, neurobiological, and disease-focused domains. This article provides mechanistic insight, strategic guidance, and evidence-backed perspectives for leveraging SAH as a methylation cycle regulator, backed by recent advances and actionable recommendations for experimental design.
-
S-Adenosylhomocysteine: Master Regulator of Methylation a...
2025-10-01
Explore how S-Adenosylhomocysteine (SAH) acts as a pivotal methylation cycle regulator and metabolic enzyme intermediate, with deep insights into its mechanism, research applications, and its role in disease models. Uncover the latest scientific findings and advanced uses of SAH in metabolic and neurobiological research.
-
Ionomycin Calcium Salt: Decoding Calcium Signaling in Can...
2025-09-30
Explore the multifaceted role of ionomycin calcium salt, a potent calcium ionophore, in modulating intracellular Ca2+ signaling, apoptosis, and tumor suppression. This article uniquely bridges molecular mechanisms with translational cancer research, offering new insights for investigators.
-
CB-5083: Advanced Disruption of Protein Degradation Pathw...
2025-09-29
Discover how CB-5083, a selective p97 inhibitor, redefines cancer research by targeting protein degradation and unfolded protein response. This article uniquely explores CB-5083’s mechanistic depth, translational applications, and emerging insights in ER membrane regulation.
-
Biotin-tyramide: Precision Signal Amplification in Immune...
2025-09-28
Explore how Biotin-tyramide empowers enzyme-mediated signal amplification for dissecting immune signaling and drug discovery. This article uniquely connects tyramide-based amplification to chemoproteomic advances and autoimmune disease research.
-
Brefeldin A: Mechanisms and Advanced Oncology Applications
2025-09-27
Explore how Brefeldin A (BFA), a potent ATPase and vesicle transport inhibitor, is revolutionizing research in protein trafficking, ER stress, and cancer cell apoptosis. Discover its unique mechanistic insights and advanced biomedical applications.
-
Torin 1: Advancing mTOR Inhibition in Lipid Metabolism an...
2025-09-26
Discover how Torin 1, a potent mTOR inhibitor, is transforming mTOR signaling pathway research by enabling unprecedented insights into lipid metabolism, cell proliferation inhibition, and therapeutic modeling. This article explores unique experimental strategies and mechanistic depth not covered elsewhere.
-
Phosbind Acrylamide: Mechanistic Insights for Antibody-Fr...
2025-09-25
Discover how Phosbind Acrylamide, a leading phosphate-binding reagent, enables in-depth, antibody-free protein phosphorylation analysis through its unique mechanism of action. This article explores advanced mechanistic principles, key applications in signaling research, and new insights into phosphorylation-dependent mobility shifts.
-
Genotyping Kit for Target Alleles: Mechanistic Insights &...
2025-09-24
Explore the Genotyping Kit for target alleles of insects, tissues, fishes and cells—a rapid genomic DNA preparation kit enabling efficient PCR amplification of genomic DNA. This article uniquely reveals the mechanistic underpinnings, contamination prevention strategies, and advanced research applications, setting it apart from existing resources.
-
Nonivamide: TRPV1 Agonism and Mitochondrial Apoptosis in ...
2025-09-23
Explore the multifaceted role of Nonivamide, a capsaicin analog and TRPV1 receptor agonist, as an anti-proliferative agent for cancer research. This article analyzes its distinct mitochondrial apoptosis mechanisms and in vivo tumor inhibition, with a focus on translational experimental strategies.
-
On the other hand there was no
2025-03-03

On the other hand, there was no difference in effectiveness performing ALK by FISH with regard to the sample site. When it was extracted from the primary tumor, we obtained 27.4% of not-evaluable specimens. Similar percentages were found for node (26.7%) and tie2 (31.3%) samples (p = 0.903). Disc
-
COPD is almost unheard of in individuals less than years
2025-03-03

COPD is almost unheard of in individuals less than 40 years of age (even among heavy smokers), 1 in 10 lifetime never-smokers and 1 in 3 develop COPD by age 75 [26], unquestionably, COPD is an age-related disorder. This notion of accelerated ageing of COPD is supported by animal models, which demons
16198 records 13/1080 page Previous Next First page 上5页 1112131415 下5页 Last page